Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study.
Gaglio D, Valtorta S, Ripamonti M, Bonanomi M, Damiani C, Todde S, Negri AS, Sanvito F, Mastroianni F, Di Campli A, Turacchio G, Di Grigoli G, Belloli S, Luini A, Gilardi MC, Colangelo AM, Alberghina L, Moresco RM.
Gaglio D, et al. Among authors: damiani c.
Oncotarget. 2016 Aug 9;7(32):52017-52031. doi: 10.18632/oncotarget.10470.
Oncotarget. 2016.
PMID: 27409831
Free PMC article.